Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 26 Jul 23 EFFECT Notice of effectiveness
- 24 Jul 23 POS AM Prospectus update (post-effective amendment)
- 26 Sep 22 424B3 Prospectus supplement
- 15 Aug 22 424B3 Prospectus supplement
- 1 Jun 22 424B3 Prospectus supplement
- 18 May 22 424B3 Prospectus supplement
- 7 Apr 22 424B3 Prospectus supplement
- 7 Apr 22 EFFECT Notice of effectiveness
-
5 Apr 22 POS AM Prospectus update (post-effective amendment)
- 17 Mar 22 424B3 Prospectus supplement
- 15 Feb 22 424B3 Prospectus supplement
- 15 Feb 22 EFFECT Notice of effectiveness
- 7 Feb 22 S-1 IPO registration
GRNA similar filings
Filing view
External links
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the use in this Registration Statement No. 333-262574 on Form S-1 of our report dated March 31, 2022, relating to the financial statements of GreenLight Biosciences, Inc. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ Deloitte & Touche LLP
Boston, Massachusetts
April 5, 2022